Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
BMC Psychiatry|September 26, 2018
Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesiaStanley N Caroff, Fan Mu, Rajeev Ayyagari, et al.Journal of Child Neurology|May 10, 2023
Meaningful Improvements in Rett Syndrome: A Qualitative Study of CaregiversSarah A McGraw, Constance Smith-Hicks, James Nutter, et al.Journal of Comparative Effectiveness Research|October 27, 2025
Real-world evidence of pimavanserin utilization among patients with Parkinson's disease psychosis: a review of real-world data that augments data from randomized controlled trialsNazia Rashid, Ismaeel Yunusa, Dilesh Doshi, et al.Neurology and Therapy|May 11, 2025
The Modified Functional Status Questionnaire for Assessing Patients with Parkinson's Disease Psychosis Treated with Pimavanserin: A Post Hoc AnalysisVirgilio G H Evidente, Lambros Chrones, Ratna Revankar, et al.Journal of Huntington'S Disease|October 5, 2018
Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart ReviewDaniel O Claassen, Ravi G Iyer, Bijal Shah-Manek, et al.Journal of Huntington'S Disease|August 23, 2017
Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's DiseaseAndrew McGarry, Karl Kieburtz, Victor Abler, et al.Parkinsonism & Related Disorders|August 27, 2018
Abnormalities on structural MRI associate with faster disease progression in multiple system atrophyFlorian Krismer, Klaus Seppi, Gregor K Wenning, et al.Parkinsonism & Related Disorders|December 19, 2023
Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY TrialDaniel Weintraub, Alberto J Espay, Vibhash D Sharma, et al.Clinical Gerontologist|August 9, 2021
Symptoms and Treatment Needs of People with Dementia-Related Psychosis: A Mixed-Methods Study of the Patient ExperienceTeresa Brandt, Theresa Frangiosa, Virginia Biggar, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2016
Long-term effects of rasagiline and the natural history of treated Parkinson's diseaseOlivier Rascol, Robert A Hauser, Fabrizio Stocchi, et al.Pageof 5